Syntal Capital Partners’s CME Group CME Stock Holding History

Syntal Capital Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,924	Closed	-$373K	–	244
2019 Q2	$373K	Sell	1,924 -578	-23%	-$107K	0.08%	182
2019 Q1	$411K	Buy	2,502 +639	+34%	+$113K	0.19%	80
2018 Q4	$353K	Sell	1,863 -753	-29%	-$139K	0.22%	51
2018 Q3	$445K	Buy	2,616 +481	+23%	+$81K	0.16%	98
2018 Q2	$349K	Sell	2,135 -169	-7%	-$27.6K	0.13%	110
2018 Q1	$372K	Sell	2,304 -237	-9%	-$37.7K	0.13%	102
2017 Q4	$371K	Buy	2,541 +197	+8%	+$28.1K	0.11%	120
2017 Q3	$318K	Buy	2,344 +577	+33%	+$72.9K	0.23%	77
2017 Q2	$221	Buy	+1,767	New	+$211K	0.05%	84
2014 Q3	–	Sell	-178	Closed	-$13K	–	205
2014 Q2	$13K	Hold	178	–	–	0.01%	190
2014 Q1	$13	Buy	+178	New	+$13.4K	0.01%	117

Other funds holding CME

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Syntal Capital Partners's CME Position: Q3 2019 in Review

Syntal Capital Partners sold out of CME Group (CME) in Q3 2019, closing a stake of 1,924 shares — an estimated $373K sold.

Syntal Capital Partners first reported a position in CME in Q1 2014 and held it in 11 quarters. The position peaked at $445K in Q3 2018. 991 funds tracked by Wall St. Rank hold CME as of Q3 2019.

Syntal Capital Partners reported no remaining CME Group position as of Q3 2019 after selling out during the quarter.
Syntal Capital Partners sold 1,924 CME Group shares in Q3 2019, an estimated $373K.
Syntal Capital Partners first reported a position in CME Group in Q1 2014 and held it in 11 quarters.
Syntal Capital Partners's CME Group position peaked at $445K in Q3 2018.
991 funds tracked by Wall St. Rank held CME Group as of Q3 2019.

Based on Syntal Capital Partners's 13F filing for Q3 2019, filed 14 Nov 2019.